Last updated on March 2019

A Study to Assess the Safety Tolerability and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral Sclerosis


Brief description of study

The primary objective of this study is to evaluate the safety and tolerability of BIIB078 in adults with C9ORF72-ALS. The secondary objective of this study is to evaluate the pharmacokinetic profile of BIIB078.

Clinical Study Identifier: NCT03626012

Contact Investigators or Research Sites near you

Start Over

US Biogen Clinical Trial Center

Research Site
La Jolla, CA United States
  Connect »

US Biogen Clinical Trial Center

Research Site
Baltimore, MD United States
  Connect »

US Biogen Clinical Trial Center

Research Site
Boston, MA United States
  Connect »

US Biogen Clinical Trial Center

Research Site
Knoxville, TN United States
  Connect »

US Biogen Clinical Trial Center

Research Site
Cambridge, MA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.